HRMY
Harmony Biosciences Holdings Inc
Price:  
28.50 
USD
Volume:  
638,634.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRMY WACC - Weighted Average Cost of Capital

The WACC of Harmony Biosciences Holdings Inc (HRMY) is 7.8%.

The Cost of Equity of Harmony Biosciences Holdings Inc (HRMY) is 8.00%.
The Cost of Debt of Harmony Biosciences Holdings Inc (HRMY) is 7.00%.

Range Selected
Cost of equity 6.70% - 9.30% 8.00%
Tax rate 17.50% - 24.80% 21.15%
Cost of debt 4.50% - 9.50% 7.00%
WACC 6.4% - 9.1% 7.8%
WACC

HRMY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.62 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.70% 9.30%
Tax rate 17.50% 24.80%
Debt/Equity ratio 0.11 0.11
Cost of debt 4.50% 9.50%
After-tax WACC 6.4% 9.1%
Selected WACC 7.8%